1. Power BM, Van Heerden PV. The physiological changes associated with brain death-- current concepts and implications for treatment of the brain dead organ donor. Anaesth Intensive Care. 1995;23:26-36.
2. Smith M. Physiologic changes during brain stem death--lessons for management of the organ donor. J Heart Lung Transplant. 2004;23:S217-22.
3. Salter DR, Dyke CM, Wechsler AS. Triiodothyronine (T3) and cardiovascular therapeutics: A review. J Card Surg. 1992;7:363-374.
4. Novitzky D, Horak A, Cooper DK, Rose AG. Electrocardiographic and histopathologic changes developing during experimental brain death in the baboon. Transplant Proc. 1989;21:2567-2569.
5. Cooper DK, Novitzky D, Wicomb WN. The pathophysiological effects of brain death on potential donor organs, with particular reference to the heart. Ann R Coll Surg Engl. 1989;71:261-266.
6. Novitzky D, Cooper DK, Reichart B. Value of triiodothyronine (T3) therapy to braindead potential organ donors. J Heart Transplant. 1986;5:486-487.
7. Novitzky D, Cooper DK, Reichart B. Hemodynamic and metabolic responses to hormonal therapy in brain-dead potential organ donors. Transplantation. 1987;43:852- 854.
8. Wicomb WN, Cooper DK, Novitzky D. Impairment of renal slice function following brain death, with reversibility of injury by hormonal therapy. Transplantation. 1986;41:29-33.
9. Novitzky D, Cooper DK, Morrell D, Isaacs S. Change from aerobic to anaerobic metabolism after brain death, and reversal following triiodothyronine therapy. Transplantation. 1988;45:32-36.
10. Smrcka M, Mrlian A, Klabusay M. Immune system status in the patients after severe brain injury. Bratisl Lek Listy. 2005;106:144-146.
11. Bredbacka S, Edner G. Soluble fibrin and D-dimer as detectors of hypercoagulability in patients with isolated brain trauma. J Neurosurg Anesthesiol. 1994;6:75-82.
12. Pathak A, Dutta S, Marwaha N, Singh D, Varma N, Mathuriya SN. Change in tissue thromboplastin content of brain following trauma. Neurol India. 2005;53:178-182.
13. Stein SC, Smith DH. Coagulopathy in traumatic brain injury. Neurocrit Care. 2004;1:479-488.
14. Bayir A, Kalkan E, Kocak S, Ak A, Cander B, Bodur S. Fibrinolytic markers and neurologic outcome in traumatic brain injury. Neurol India. 2006;54:363-365.
15. Nekludov M, Antovic J, Bredbacka S, Blomback M. Coagulation abnormalities associated with severe isolated traumatic brain injury: Cerebral arterio-venous differences in coagulation and inflammatory markers. J Neurotrauma. 2007;24:174-180.
16. Affonseca CA, Carvalho LF, Guerra SD, Ferreira AR, Goulart EM. Coagulation disorder in children and adolescents with moderate to severe traumatic brain injury. J Pediatr (Rio J). 2007;83:274-282.
17. Aiyagari V, Menendez JA, Diringer MN. Treatment of severe coagulopathy after gunshot injury to the head using recombinant activated factor VII. J Crit Care. 2005;20:176-179.
18. Novitzky D, Cooper DK, Chaffin JS, Greer AE, DeBault LE, Zuhdi N. Improved cardiac allograft function following triiodothyronine therapy to both donor and recipient. Transplantation. 1990;49:311-316.
19. Novitzky D. Novel actions of thyroid hormone: The role of triiodothyronine in cardiac transplantation. Thyroid. 1996;6:531-536.
20. Zuppa AF, Nadkarni V, Davis L, et al. The effect of a thyroid hormone infusion on vasopressor support in critically ill children with cessation of neurologic function. Crit Care Med. 2004;32:2318-2322.
21. Salim A, Martin M, Brown C, Belzberg H, Rhee P, Demetriades D. Complications of brain death: Frequency and impact on organ retrieval. Am Surg. 2006;72:377-381.
22. Novitsky D, Cooper DKC, Rosendale JD, Kauffman HM. Hormonal therapy of the brain-dead organ donor: experimental and clinical studies. Transplantation. 2006; 82(11): 1396-1401
23. Rech TH, Moraes RB, Crispin D, et. al. Management of the brain-dead organ donor: a systematic review and meta-analysis, Transplantation. 2013; 95(7): 966 -74.
24. McKeown DW, Ball J. Treating the donor. Current Opinion in Organ Transplantation. 2014; 19:85-91.
25. Powner DJ, Boccalandro C. Adrenal insufficiency following traumatic brain injury in adults. Curr Opin Crit Care. 2008 Apr;14(2):163-6.
26. Klose M, Juul A, Poulsgaard L, Kosteljanetz M, Brennum J, Feldt-Rasmussen U. Prevalence and predictive factors of post-traumatic hypopituitarism. Clin Endocrinol (Oxf). 2007 Aug;67(2):193-201. Epub 2007 May
27. Powner DJ, Boccalandro C, Alp MS, Vollmer DG. Endocrine failure after traumatic brain injury in adults. Neurocrit Care. 2006;5(1):61-70.
28. Aimaretti G, Ambrosio MR, Di Somma C, Fusco A, Cannavò S, Gasperi M, Scaroni C, De Marinis L, Benvenga S, degli Uberti EC, Lombardi G, Mantero F, Martino E, Giordano G, Ghigo E. Traumatic brain injury and subarachnoid haemorrhage are conditions at high risk for hypopituitarism: screening study at 3 months after the brain injury. Clin Endocrinol (Oxf). 2004 Sep;61(3):320-6.
29. Dimopoulou I, Tsagarakis S, Kouyialis AT, Roussou P, Assithianakis G, Christoforaki M, Ilias I, Sakas DE, Thalassinos N, Roussos C. Hypothalamic-pituitary-adrenal axis dysfunction in critically ill patients with traumatic brain injury: incidence, pathophysiology, and relationship to vasopressor dependence and peripheral interleukin-6 levels. Crit Care Med. 2004 Feb;32(2):404-8.
30. Hebert PC, Wells G, Blajchman MA, et al: A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N Engl J Med 1999; 340:409-417.
31. Kotloff RM, Blosser SD, Fulda GJ, et al: Management of the Potential Organ Donor in the ICU: Society of Critical Care Medicine/ Americal College of Chest Physicians/ Association of Organ Procurement Organizations Consensus Statement. Crit Care Med 2015; 43:1291-1325.